Concepedia
Statistics
Publications
3
Citations
135
H-Index
Active since
2017
Affiliations
Hôpital Lyon Sud(Current)
Novartis (United States)
O Kong is an author at Hôpital Lyon Sud specializing in cancer pharmacology, oncology, and medicine.
Publications per year
2017–2019
Phase II Study of BEZ235 versus Everolimus in Patients with Mammalian Target of Rapamycin Inhibitor-Naïve Advanced Pancreatic Neuroendocrine Tumors
Ramón Salazar, Rocio García‐Carbonero, Steven K. Libutti et al. · The Oncologist · 2017 · 77 citations · Full text
Medicine, Oncology, Pharmacology +13
Pan-phosphatidylinositol 3-kinase inhibition with buparlisib in patients with relapsed or refractory non-Hodgkin lymphoma
Anas Younes, Gilles Salles, Giovanni Martinelli et al. · Haematologica · 2017 · 46 citations · Full text
Medicine, Oncology, Pharmacology +14
Abstract P6-18-06: Ribociclib treatment benefit in patients with advanced breast cancer with ≥1 dose reduction: Data from the MONALEESA-2, -3, and -7 trials
J. Thaddeus Beck, Patrick Neven, Joohyuk Sohn et al. · Cancer Research · 2019 · 12 citations
Medicine, Oncology, Pharmacology +16
1–3 of 3